Abzena PLC (ABZA) Given Buy Rating at FinnCap
Abzena PLC (LON:ABZA)‘s stock had its “buy” rating reissued by investment analysts at FinnCap in a research report issued on Wednesday, May 24th. They presently have a GBX 80 ($1.01) target price on the stock. FinnCap’s price objective indicates a potential upside of 92.77% from the company’s previous close.
Several other brokerages also recently commented on ABZA. N+1 Singer reiterated a “corporate” rating on shares of Abzena PLC in a report on Tuesday, February 21st. Numis Securities Ltd reiterated a “buy” rating and issued a GBX 90 ($1.14) target price on shares of Abzena PLC in a report on Tuesday, February 21st.
Shares of Abzena PLC (LON:ABZA) traded down 3.49% on Wednesday, hitting GBX 41.50. 108,667 shares of the stock were exchanged. The stock’s market cap is GBX 56.85 million. The stock’s 50-day moving average is GBX 37.16 and its 200-day moving average is GBX 37.00. Abzena PLC has a 1-year low of GBX 31.00 and a 1-year high of GBX 66.00.
About Abzena PLC
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.
Receive News & Stock Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related stocks with our FREE daily email newsletter.